Work

A phase 1/2 clinical trial of quaratusugene ozeplasmid gene therapy and atezolizumab maintenance therapy in patients with extensive stage small cell lung cancer (ES-SCLC).

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps8126

Authors: Bo Wang, Kartik Konduri, Robert M. Jotte, Donald A. Richards, Rachel E. Sanborn, Alexander I. Spira, David Michael Waterhouse, Katherin Combs, Jacqueline Opiola, Mark S. Berger, Daniel Morgensztern

Institutions: Willamette Valley Cancer Institute and Research Center, Texas Oncology, Rocky Mountain Cancer Centers, Providence Portland Medical Center, Oncology Hematology Care, Washington University in St. Louis

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410816260

Cites:

Cited by:

Related to: 10